论文部分内容阅读
本文报告了以尿激酶半球后注射治疗各种类型的外伤性玻璃体出血38例。注射尿激酶加速了出血的吸收。疗效以视力增加情况和玻璃体变清时间两个方面来判定。38例中,显效者8例占21%;有效者18例占48.3%;无效者9例占23.6%;退步者3例占7.8%。作者认为尿激酶注射时间最好选择在受伤后2~3周内进行,不必担心因尿激酶注射而引起继发性玻璃体出血。
This article reports 38 cases of various types of traumatic vitreous hemorrhage treated with a hemithrombin injection. Injection of urokinase accelerates the absorption of bleeding. Efficacy of visual acuity and vitreous clear time to determine the two aspects. Among the 38 cases, 8 cases were markedly effective, 21% were effective, 18 cases were effective, 48.3% were ineffective, 9 cases were ineffective, 23.6% were retroviral, and 3 cases were retrogressive, accounting for 7.8%. The authors believe that the best choice of urokinase injection time within 2 to 3 weeks after injury, do not have to worry about secondary vitreous hemorrhage caused by urokinase injection.